Thompson Siegel & Walmsley LLC
- SEC CIK
- 0001008322
- Latest filing
- Aug 11, 2026
HAE holding history
Haemonetics Corp in every 13F filed by Thompson Siegel & Walmsley LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HAE overviewAll 13F holders of HAEFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −9,000−100.0% | Sold out | Holders |
| Q1 2025 | 9,000 | $572.0K | <0.1% | +9,000 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −22−100.0% | Sold out | Holders |
| Q4 2022 | 22 | $2.00K | <0.1% | −173,268−100.0% | Reduced | Holders |
| Q3 2022 | 173,290 | $12.8M | 0.2% | −69,723−28.7% | Reduced | Holders |
| Q2 2022 | 243,013 | $15.8M | 0.3% | −36,129−12.9% | Reduced | Holders |
| Q1 2022 | 279,142 | $17.6M | 0.3% | −9,731−3.4% | Reduced | Holders |
| Q4 2021 | 288,873 | $15.3M | 0.2% | +47,110+19.5% | Added | Holders |
| Q3 2021 | 241,763 | $17.1M | 0.2% | −78,650−24.5% | Reduced | Holders |
| Q2 2021 | 320,413 | $21.4M | 0.3% | +320,413 | New | Holders |